Impact of Helicobacter pylori Infection and Outcome of Anti-Helicobacter pylori Therapy in Patients with Reflux Laryngopharyngitis

Table 5

RSI and RFS before and after treatment.

Group	n	RSI			RFS
Control	145	32.67 ± 0.41	18.07 ± 1.05	≤0.001	21.66 ± 1.22	15.44 ± 0.54	<0.001
Hp therapy	145	32.65 ± 0.70	11.50 ± 1.73	≤0.001	21.72 ± 0.82	12.97 ± 1.50	<0.001
		0.722	≤0.001		0.279	<0.001

Hp = Helicobacter pylori.